Deborah Dodge

Deborah Dodge is an experienced scientist with a robust background in cell biology, drug discovery, and project leadership within the biotechnology and pharmaceutical industries. Currently serving as Discovery Technology at Sail Biomedicines, Deborah has held positions at the Wyss Institute for Biologically Inspired Engineering, Cyclerion, and Ironwood Pharmaceuticals, where significant contributions to various projects were made. Previous roles include project leadership in oncology and metabolic disease at Ensemble Therapeutics and technical lead responsibilities at Anchor Therapeutics. Deborah's foundational experience includes research investigator positions at Resolvyx Pharmaceuticals, Critical Therapeutics, and Millennium Pharmaceuticals, emphasizing high-throughput biochemistry and assay development. Deborah earned a Bachelor of Science degree in Microbiology from the University of Massachusetts Amherst.